UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054109
Receipt number R000059987
Scientific Title Activity characteristics of the thenar muscle in Kapandji test
Date of disclosure of the study information 2024/05/01
Last modified on 2024/04/10 17:58:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Activity characteristics of the thenar muscle in Kapandji test

Acronym

Activity characteristics of the thenar muscle in Kapandji test

Scientific Title

Activity characteristics of the thenar muscle in Kapandji test

Scientific Title:Acronym

Activity characteristics of the thenar muscle in Kapandji test

Region

Japan


Condition

Condition

opposable thumb disorder

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate muscle activity in each test position in the Kapandji test, which is widely used to assess the function of the thumb, and to determine the contribution of each muscle in each position.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Muscle activity by electromyography

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Pinch Power Demonstration

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

22 years-old <

Age-upper limit

45 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy volunteers

Key exclusion criteria

Any pre-existing orthopedic or neuromuscular disease

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Chihio
Middle name
Last name FUJIME

Organization

Niigata University of Health and Walefer

Division name

Depertoment of Occupational Therapy

Zip code

9503198

Address

1398, Shimami-cho, Kita-ku, Niigatashi, Niigata

TEL

0252574496

Email

fujime@nuhw.ac.jp


Public contact

Name of contact person

1st name Chihiro
Middle name
Last name FUJIME

Organization

Niigata University of Health and Welfare

Division name

Depertment of Occupational Therapy

Zip code

9503198

Address

1398, shimamicho, Kita-ku, Niigatashi, Niigata

TEL

0252574496

Homepage URL


Email

fujime@nuhw.ac.jp


Sponsor or person

Institute

Niigata University of Health and Walefer

Institute

Department

Personal name



Funding Source

Organization

Niigata University of Health and Walefer

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University of Health and Walefer

Address

1398, shimamicho, Kita-ku, Niigatashi, Niigata

Tel

rinri@nuhw.ac.jp

Email

025-257-4455


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 10 Day

Last modified on

2024 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059987